arginine and Carcinoma, Lobular

arginine has been researched along with Carcinoma, Lobular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexandre, CO; Damin, AP; Damin, DC; Frazzon, AP; Hermes, V; Roehe, A; Zettler, C1
Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG1

Trials

1 trial(s) available for arginine and Carcinoma, Lobular

ArticleYear
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.
    International journal of oncology, 1998, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine

1998

Other Studies

1 other study(ies) available for arginine and Carcinoma, Lobular

ArticleYear
Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Cancer detection and prevention, 2006, Volume: 30, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Arginine; Brazil; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Risk Factors

2006